Home > Expert Committee on Drug Dependence information repository.

WHO Expert Committee on Drug Dependence. (2023) Expert Committee on Drug Dependence information repository.

External website: https://ecddrepository.org/en


The ECDD Information Repository is an open access database containing publications and information on psychoactive substances reviewed by the WHO Expert Committee on Drug Dependence (ECDD).

The purpose of the repository is to provide the public, academics, health professionals, law enforcement and government staff an easy interface to find technical information about psychoactive substances that have been reviewed by the ECDD. Users are able to search and extract information from published Technical Reports, Critical Review and Pre-review reports. In addition, the repository provides an overview on the recommendations proposed by the WHO to the international community and the current scheduling status of each psychoactive substance reviewed.

Item Type
Webpage
Publication Type
International, Audio / Visual
Drug Type
New psychoactive substance
Intervention Type
Screening / Assessment
Source
Date
October 2023
Publisher
World Health Organization
Corporate Creators
WHO Expert Committee on Drug Dependence
Place of Publication
Geneva
EndNote
Subjects
A Substance use and dependence > Effects or consequences
B Substances > Cannabis product (Cannabinoids) > Cannabinol / Cannabidiol (CBD oil)
B Substances > Inhalants and solvents > Nitrous oxide (laughing gas)
B Substances > Opioids (opiates)
B Substances > New (novel) psychoactive substances > Aminoindanes / Arylalkylamines / Arylcyclohexylamines > Ketamine
B Substances > New (novel) psychoactive substances > Piperidines-pyrrolidines / Piperazine derivates > BZP (Benzylpiperazine)
B Substances > New (novel) psychoactive substances > Plants and extracts > Khat
B Substances > New (novel) psychoactive substances > Synthetic cannabinoids (Spice / K2 / OXIZID / HHC)
B Substances > New (novel) psychoactive substances > Synthetic cathinones
B Substances > New (novel) psychoactive substances > Synthetic opioids
B Substances > New (novel) psychoactive substances > Other novel substances > Gabapentinoids GABA (Pregabalin / Gabapentin)
B Substances > New (novel) psychoactive substances > Other novel substances > GHB / GBL (Gamma hydroxybutyric / Gamma butyrolactone)
B Substances > New (novel) psychoactive substances > Other novel substances > Zopiclone, eszopiclone, zaleplon and zolpidem
E Concepts in biomedical areas > Pharmacology and toxicology
J Health care, prevention, harm reduction and treatment > Risk and needs assessment > Risk assessment
J Health care, prevention, harm reduction and treatment > Identification and screening > Identification and screening for substance use > Drug checking / testing service
MM-MO Crime and law > Substance use laws > Drug laws
VA Geographic area > International

Repository Staff Only: item control page